Surotomycin (a novel cyclic lipopeptide) vs Vancomycin for treatment of Clostridioides difficile infection: A systematic review and Meta-analysis.

CONCLUSION: Surotomycin is non-inferior to vancomycin and offers a promising alternative for the treatment and prevention of C. diff infection. .
PMID: 30924421 [PubMed - as supplied by publisher]

Source: Current Clinical Pharmacology - March 27, 2019 Category: Drugs & Pharmacology Authors: Aziz M, Desai M, Fatima R, Chandrasekar VT, Eid A, Jackson M, Sharma P Tags: Curr Clin Pharmacol Source Type: research